| Literature DB >> 35276674 |
Steven M Horwitz1, Stephen Ansell2, Weiyun Z Ai3, Jeffrey Barnes4, Stefan K Barta5, Jonathan Brammer6, Mark W Clemens7, Ahmet Dogan1, Francine Foss8, Paola Ghione9, Aaron M Goodman10, Joan Guitart11, Ahmad Halwani12, Bradley M Haverkos13, Richard T Hoppe14, Eric Jacobsen15, Deepa Jagadeesh16, Allison Jones17, Avyakta Kallam18, Youn H Kim14, Kiran Kumar19, Neha Mehta-Shah20, Elise A Olsen21, Saurabh A Rajguru22, Sima Rozati23, Jonathan Said24, Aaron Shaver25, Lauren Shea26, Michi M Shinohara27, Lubomir Sokol28, Carlos Torres-Cabala7, Ryan Wilcox29, Peggy Wu30, Jasmine Zain31, Mary Dwyer32, Hema Sundar32.
Abstract
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase-negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas.Entities:
Mesh：
Year: 2022 PMID： 35276674 DOI： 10.6004/jnccn.2022.0015
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 12.693